Sarcoidosis-Lymphoma Syndrome presenting by severe Cholestatic Hepatitis
Journal Title: Archives of Hepatitis Research - Year 2017, Vol 3, Issue 1
Abstract
Severe cholestatic hepatitis is an uncommon presentation of either sarcoidosis or Hodgkin lymphoma. Sarcoidosis lymphoma syndrome is a rare disorder with sarcoidosis heralding the onset of lymphoma. Here we report a case of coexisting sarcoidosis-Hodgkin’s lymphoma syndrome presenting with severe cholestatic hepatitis.
Authors and Affiliations
Alhaddad Omkolsoum M, Elsabaawy Maha M, Shaarawy Omar A, Ehsan Nermine A, Maher Doha, Gmeel Khaled, Rewisha Eman A, Waked Imam A
Keywords
Related Articles
- EP ID EP559384
- DOI 10.17352/ahr.000012
- Views 38
- Downloads 0
Occupational Hazard (Hepatitis B & C)
Hepatitis B and C are considered as an important health hazard among health care workers (HCWs). These blood borne infections can be transmitted either from HCW to a patient or vice-versa. Both viruses are known to cause...
Accidentally discovered Portal Vein Thrombosis before Splenectomy due to Hypersplenism - The role of Thrombogenic Genes Polymorphisms
Portal vein thrombosis in patients with liver cirrhosis may be due neoplastic growth invading portal vein or due to non-neoplastic causes. The indications for treating PVT in cirrhotic individuals are difficult to be est...
Hepatitis E: New Clinical and Public Health Problem on the Western World? Review
Until recently, the occurrence of Hepatitis E in the western hemisphere did not amount to a clinical concern, due to its benign and usually sub-clinical evolution, as opposed to Asia and Africa, where large epidemies wit...
Hepatitis E: Diagnostic and Therapeutic Challenges
HEV infection may be symptomatic or asymptomatic that has affected about one-third of world population with a case fatality rate of 1-2%, including 20-30% of infected pregnant women [3-5]. Though inherently hepatotropic...
Current Trends of Combination Therapy in Chronic Hepatitis B Management in China
In the past decade, five oral nucleos(t)ide analogs and two formulations of pegylated interferon alpha have been approved for the treatment of chronic hepatitis B (CHB). Due to low personal income and inadequate health c...